- Home
- MYGN vs MSGE Comparison
MYGN vs MSGE Comparison
Compare MYGN & MSGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- MSGE
- Stock Information
- Founded
- MYGN 1991
- MSGE 2020
- Country
- MYGN United States
- MSGE United States
- Employees
- MYGN N/A
- MSGE N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MSGE Services-Misc. Amusement & Recreation
- Sector
- MYGN Health Care
- MSGE Consumer Discretionary
- Exchange
- MYGN Nasdaq
- MSGE Nasdaq
- Market Cap
- MYGN 744.7M
- MSGE 1.9B
- IPO Year
- MYGN 1995
- MSGE N/A
- Fundamental
- Price
- MYGN $5.21
- MSGE $40.45
- Analyst Decision
- MYGN Hold
- MSGE Strong Buy
- Analyst Count
- MYGN 15
- MSGE 6
- Target Price
- MYGN $15.14
- MSGE $49.83
- AVG Volume (30 Days)
- MYGN 1.4M
- MSGE 398.0K
- Earning Date
- MYGN 08-05-2025
- MSGE 08-15-2025
- Dividend Yield
- MYGN N/A
- MSGE N/A
- EPS Growth
- MYGN N/A
- MSGE 157.00
- EPS
- MYGN N/A
- MSGE 2.72
- Revenue
- MYGN $831,300,000.00
- MSGE $974,670,000.00
- Revenue This Year
- MYGN N/A
- MSGE N/A
- Revenue Next Year
- MYGN $6.68
- MSGE $6.68
- P/E Ratio
- MYGN N/A
- MSGE $14.49
- Revenue Growth
- MYGN 7.38
- MSGE 5.81
- 52 Week Low
- MYGN $3.81
- MSGE $28.29
- 52 Week High
- MYGN $29.30
- MSGE $44.14
- Technical
- Relative Strength Index (RSI)
- MYGN 50.85
- MSGE 57.72
- Support Level
- MYGN $4.90
- MSGE $37.44
- Resistance Level
- MYGN $5.83
- MSGE $40.73
- Average True Range (ATR)
- MYGN 0.28
- MSGE 0.94
- MACD
- MYGN 0.04
- MSGE -0.13
- Stochastic Oscillator
- MYGN 54.21
- MSGE 59.76
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About MSGE Madison Square Garden Entertainment Corp.
Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.